Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican...
Lyon – France, November 9th, 2023 – Alliance Promotion Microbiote (APM), a leading player dedicated to the development, production, and commercialization of therapeutic innovations based on the...
View ArticleFocus SoHO et Paquet Pharma
Depuis sa création, l’APM s’est révélée pionnière dans ses actions auprès des autorités compétentes pour les aider à appréhender les spécificités liées à l’exploitation thérapeutique du microbiote,...
View ArticleThe Alliance Promotion Microbiote is becoming the European Microbiome...
Paris – France – May 14, 2024 – The Alliance Promotion Microbiome (APM), a key player dedicated to the development, production, and commercialization of therapeutic innovations based on the...
View ArticleMicrobiota & Health Day 2023
March 9th at the Cité Internationale de la Gastronomie in LyonFor the 6th edition of its Microbiota and Health Day, organized in partnership with the Microbiota Promotion Alliance, Lyonbiopole...
View ArticleMaaT Pharma Receives U.S. FDA Response
Outlining Path Forward for Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease and Reports Cash and Revenues for Fourth Quarter 2022. Access the press...
View ArticleMaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational...
Lyon, France, April 24, 2023, 7:30 am CET – MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM...
View ArticleAlliance Promotion Microbiote applauds the new legislation securing stool...
Lyon, France, August 24th, 2023 – The Alliance Promotion Microbiote (APM), a prominent player dedicated to the development, production, and commercialization of therapeutic microbiome-based...
View ArticleEuropean Microbiome Innovation for Health and Microbiome Therapeutics...
Paris – France – September 23, 2024, 2:00 pm CET – The European Microbiome Innovation for Health (EMIH) association today announced an agreement between the Microbiome Therapeutics Innovation Group...
View ArticleEuropean Microbiome Innovation for Health and Microbiome Therapeutics...
Paris – France – September 25 2024, 4:00 pm CET – The European Microbiome Innovation for Health (EMIH) association Microbiome Times Magazine, the microbiome industry’s leading B2B publication, is...
View ArticleEMIH is a partner of the 8th edition of the Microbiota and Health Day...
The event will take place on January 23, 2025, in Lyon This day offers a unique opportunity for microbiota stakeholders (academics, clinicians, and industry leaders) to gather around current,...
View Article